Tango Therapeutics Stock Analysis

Tango Stock Analysis Notes

About 13.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.85. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Tango Therapeutics recorded a loss per share of 1.15. The entity had not issued any dividends in recent years. Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. The company was founded in 2017 and is based in Cambridge, Massachusetts. Tango Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 103 people. To find out more about Tango Therapeutics contact Barbara MD at 857 320 4900 or learn more at https://www.tangotx.com.

Tango Therapeutics Investment Alerts

Tango Therapeutics Upcoming and Recent Events

Tango Largest EPS Surprises

View All Earnings Estimates

Tango Therapeutics Environmental, Social, and Governance (ESG) Scores

Tango Stock Institutional Investors

Note, although Tango Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Tango Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 438.27 M.

Tango Profitablity

The company has Profit Margin (PM) of (2.84) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.83) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.83.

Management Efficiency

Tango Therapeutics has return on total asset (ROA) of (0.2237) % which means that it has lost $0.2237 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4879) %, meaning that it created substantial loss on money invested by shareholders. Tango Therapeutics' management efficiency ratios could be used to measure how well Tango Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.27 in 2024. Return On Capital Employed is likely to drop to -0.34 in 2024. At this time, Tango Therapeutics' Net Tangible Assets are fairly stable compared to the past year. Asset Turnover is likely to rise to 0.15 in 2024, whereas Total Assets are likely to drop slightly above 352.5 M in 2024.

Technical Drivers

As of the 2nd of December, Tango Therapeutics has the Variance of 51.8, coefficient of variation of (554.60), and Risk Adjusted Performance of (0.13). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Tango Therapeutics, as well as the relationship between them.

Tango Therapeutics Price Movement Analysis

Tango Therapeutics Insider Trading Activities

Tango Therapeutics Outstanding Bonds

Tango Therapeutics Predictive Daily Indicators

Tango Therapeutics Corporate Filings

Tango Therapeutics Forecast Models

Tango Therapeutics' time-series forecasting models are one of many Tango Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Tango Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Tango Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Tango shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Tango Therapeutics. By using and applying Tango Stock analysis, traders can create a robust methodology for identifying Tango entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Tango analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Tango analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Tango Therapeutics stock analysis indicators help investors evaluate how Tango Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Tango Therapeutics shares will generate the highest return on investment. By understating and applying Tango Therapeutics stock analysis, traders can identify Tango Therapeutics position entry and exit signals to maximize returns.

When running Tango Therapeutics' price analysis, check to measure Tango Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tango Therapeutics is operating at the current time. Most of Tango Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tango Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tango Therapeutics' price. Additionally, you may evaluate how the addition of Tango Therapeutics to your portfolios can decrease your overall portfolio volatility.